PULMOCIS

This brand name is authorized in Austria, Estonia, France, Hong Kong, Croatia, Ireland, Malta, United Kingdom

Active ingredients

The drug PULMOCIS contains one active pharmaceutical ingredient (API):

1 Technetium ⁹⁹ᵐTc macrosalb UNII ZIF514RVZR - ALBUMIN HUMAN

Technetium ⁹⁹ᵐTc macrosalb is for diagnostic use only. It is used for pulmonary perfusion scintigraphy and radionuclide venography. When administered in usual doses, technetium [99mTc] macrosalb injection shows no pharmacodynamic effects detectable clinically or/and analytically. Read about Technetium ⁹⁹ᵐTc macrosalb

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PULMOCIS Kit for radiopharmaceutical preparation	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V09EB01	Technetium (99mTc) macrosalb	V Various → V09 Diagnostic radiopharmaceuticals → V09E Respiratory system → V09EB Technetium (99mTc), particles for injection
Discover more medicines within V09EB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1385232
Country: FR	Base de données publique des médicaments	Identifier(s): 67986283
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 395330
Country: HK	Department of Health Drug Office	Identifier(s): 66231
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-430112868
Country: MT	Medicines Authority	Identifier(s): MA826/00502